Home
Resources
Publications
[Clinical Studies of Terodiline Hydrochloride and Clenbuterol Hydrochloride for Urinary Frequency and Incontinence]

[Clinical Studies of Terodiline Hydrochloride and Clenbuterol Hydrochloride for Urinary Frequency and Incontinence]

T Katsumi, K Murayama, E Tajika, T Nakamura, K Kawaguchi

Hinyokika Kiyo. 1991 Nov;37(11):1575-80.

PMID: 1767784

Abstract:

The clinical effectiveness and safety of terodiline hydrochloride and clenbuterol hydrochloride were studied on 51 patients with neurogenic bladder, stress incontinence, unstable bladder and others, the chief complaints of which were urinary frequency or urinary incontinence. Overall improvement was graded as marked in 6 patients (11.8%), moderate in 20 patients (39.2%), slight in 11 patients (21.6%), unchanged in 13 patients (25.5%) and aggravated in one. The patients impression was "good" or better in 56.9%. There were a total of 13 cases (25.5%) of adverse reactions, namely, 7 cases of finger tremor, 3 cases of dry mouth and others. These reactions disappeared rapidly after the discontinuance of drug administration. The clinical efficacy in the treatment of subjective symptoms was 71.4% for urinary incontinence, 56.4% for diurnal pollakisuria. The examination of lower urethral functions demonstrated a significant (p less than 0.01) increase in bladder capacity at first desire and maximum desire to void. However, we found no significant increase in urethral clossure pressure. The findings of this study suggest that terodiline hydrochloride and clenbuterol hydrochloride are very useful for the treatment of urinary frequency and incontinence.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP7082215	Terodiline hydrochloride		7082-21-5	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: